UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Hepatobiliary malignancies in Wilson disease

Liver international, 2015-05, Vol.35 (5), p.1615-1622

2015

Link zum Volltext

Verfügbarkeit prüfen

Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma

Journal of cancer research and clinical oncology, 2020-04, Vol.146 (4), p.1033-1050

2020

Link zum Volltext

Verfügbarkeit prüfen

Iron metabolism and the role of HFE gene polymorphisms in Wilson disease

Liver international, 2012-01, Vol.32 (1), p.165-170

2012

Link zum Volltext

Verfügbarkeit prüfen

Neurological worsening in Wilson disease – clinical classification and outcome

Journal of hepatology, 2023-08, Vol.79 (2), p.321-328

2023

Link zum Volltext

Verfügbarkeit prüfen

Exacerbation of Myopathy in Glycogen Debrancher Deficiency After Liver Transplantation: Case Report and Review of the Literature

Transplantation proceedings, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study

Transplantation proceedings, 2021-05, Vol.53 (4), p.1112-1117

2021

Link zum Volltext

Verfügbarkeit prüfen

FRI-445-Safety and efficacy of trientine treatment in Wilson disease in patients withdrawn from d-Penicillamine: Final results from a prospective study

Journal of hepatology, 2019-04, Vol.70 (1), p.e591-e592

2019

Link zum Volltext

Verfügbarkeit prüfen

THU-147 - Sequential systemic treatment in patients with hepatocellular carcinoma: real-world data in the era of immune checkpoint inhibition

Journal of hepatology, 2023-06, Vol.78, p.S594-S594

2023

Link zum Volltext

Verfügbarkeit prüfen

Sequential systemic treatment in patients with hepatocellular carcinoma: real-world data in the era of immune checkpoint inhibition

Journal of hepatology, 2023-06, Vol.78, p.S594

2023

Link zum Volltext

Verfügbarkeit prüfen

Long‐term evaluation of urinary copper excretion and non‐caeruloplasmin associated copper in Wilson disease patients under medical treatment

Journal of inherited metabolic disease, 2019-03, Vol.42 (2), p.371-380

2019

Link zum Volltext

Verfügbarkeit prüfen

The steady state pharmacokinetics of trientine in Wilson disease patients

European journal of clinical pharmacology, 2018-06, Vol.74 (6), p.731-736

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3163-3174

2022

Link zum Volltext

Verfügbarkeit prüfen

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease

Liver international, 2020-04, Vol.40 (4), p.894-904

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation

Langenbeck's archives of surgery, 2018-09, Vol.403 (6), p.719-731

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction to: The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation

Langenbeck's archives of surgery, 2022-12, Vol.407 (8), p.3919-3919

2022

Link zum Volltext

Verfügbarkeit prüfen

Wilson disease: symptomatic liver therapy

Handbook of clinical neurology, 2017, Vol.142, p.205-209

2017

Link zum Volltext

Verfügbarkeit prüfen

Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy

Journal of inherited metabolic disease, 2016-01, Vol.39 (1), p.125-130

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma

Journal of cancer research and clinical oncology, 2019-11, Vol.145 (11), p.2761-2769

2019

Link zum Volltext

Verfügbarkeit prüfen

Wilson disease: Health-related quality of life and risk for depression

Clinics and research in hepatology and gastroenterology, 2016-06, Vol.40 (3), p.349-356

2016

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data

Targeted oncology, 2024-03, Vol.19 (2), p.213-221

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment

Journal of inherited metabolic disease, 2018-06, p.1-9

2018

Link zum Volltext

Verfügbarkeit prüfen

Bone demineralisation in a large cohort of Wilson disease patients

Journal of inherited metabolic disease, 2015-09, Vol.38 (5), p.949-956

2015

Link zum Volltext

Verfügbarkeit prüfen

Factors modifying phenotypic presentation in Wilson disease: authors' reply

Liver international, 2012-05, Vol.32 (5), p.870-870

2012

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation

Langenbeck's archives of surgery, 2013-12, Vol.398 (8), p.1123-1128

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatobiliary malignancies in Wilson disease

Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma

Iron metabolism and the role of HFE gene polymorphisms in Wilson disease

Neurological worsening in Wilson disease – clinical classification and outcome

Exacerbation of Myopathy in Glycogen Debrancher Deficiency After Liver Transplantation: Case Report and Review of the Literature

Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)

SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study

FRI-445-Safety and efficacy of trientine treatment in Wilson disease in patients withdrawn from d-Penicillamine: Final results from a prospective study

THU-147 - Sequential systemic treatment in patients with hepatocellular carcinoma: real-world data in the era of immune checkpoint inhibition

Sequential systemic treatment in patients with hepatocellular carcinoma: real-world data in the era of immune checkpoint inhibition

Long‐term evaluation of urinary copper excretion and non‐caeruloplasmin associated copper in Wilson disease patients under medical treatment

The steady state pharmacokinetics of trientine in Wilson disease patients

Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease

The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation

Correction to: The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation

Wilson disease: symptomatic liver therapy

Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy

Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma

Wilson disease: Health-related quality of life and risk for depression

Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data

Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment

Bone demineralisation in a large cohort of Wilson disease patients

Factors modifying phenotypic presentation in Wilson disease: authors' reply

Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation

Aktive Filter

Suchergebnisse filtern